首页> 外文OA文献 >The Effect of Platelet Lysate as a Medium Supplement in Cultures of Human Multiple Myeloma
【2h】

The Effect of Platelet Lysate as a Medium Supplement in Cultures of Human Multiple Myeloma

机译:血小板裂解液作为培养基补充剂在人多发性骨髓瘤培养中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multiple myeloma (MM) is a cancer of antibody-producing plasma cells in the bone marrow. It is the second most frequent hematological malignancy and comprises 1 % of all cancer. Most human myeloma cell lines (hMCLs) derived from MM patients are cultured in animal serum. However, the hMCLs KJON, OH-2 and IH-1 established at the Department of Cancer Research and Molecular Medicine in Trondheim are cultured in a growth medium supplemented with human serum (HS), since it has been impossible to keep them alive for extended periods in animal serum. HS is provided by the blood bank at St. Olavs University Hospital in Trondheim, but the access is intermittently poor and the use of HS is otherwise economically and ethically unfavorable. The aim of this thesis was to study the effect of platelet lysate (PL) as an alternative medium supplement to HS in cultures with the MM cell lines KJON, OH-2 and IH-1. Platelet lysate is known to contain large amount of various growth factors and has been shown to be effective in stimulating proliferation of other cell types. Flow cytometry and CellTiter-Glo assay were performed to study apoptosis and proliferation respectively in various conditions with PL and HS. Long-term cultivation of cells was performed to test the proliferative effect of PL over time. Long-term cultivation showed that IH-1 cells could utilize PL as a medium supplement to some extent, but proliferation was too slow to consider PL as a good alternative to HS. OH-2 cells did not proliferate in PL over extended periods of time, and the cells seem to be impossible to wean from their dependence on HS. KJON cells had a slower proliferation rate in PL compared to HS. Apoptosis assay showed in general small differences in the percentage of viability among the cells cultured in HS and PL, while proliferation assay revealed that HS is more effective in stimulating proliferation of the cells of the respective cell lines. If HS is to be replaced by an alternative medium supplement, this type of medium should give a stable and high proliferative effect on the cells and support growth and survival at the same extent as HS. PL cannot substitute HS because it does not contribute to optimal growth and proliferation of the cell lines IH-1, KJON and OH-2. The processing of PL was also time-consuming and less practical than for HS.
机译:多发性骨髓瘤(MM)是骨髓中产生抗体的浆细胞的癌症。它是第二常见的血液系统恶性肿瘤,占所有癌症的1%。大多数来自MM患者的人类骨髓瘤细胞系(hMCL)在动物血清中培养。然而,在特隆赫姆癌症研究和分子医学系建立的hMCL KJON,OH-2和IH-1在补充了人血清(HS)的生长培养基中进行培养,因为不可能使其长期存活。动物血清中的时间。 HS由特隆赫姆的圣奥拉夫斯大学医院的血库提供,但间歇性出入较差,否则在经济和伦理上不利于HS的使用。本文的目的是研究在具有MM细胞系KJON,OH-2和IH-1的培养物中,血小板溶解产物(PL)作为HS替代培养基的作用。已知血小板裂解物含有大量的各种生长因子,并已显示出可有效刺激其他细胞类型的增殖。进行流式细胞术和CellTiter-Glo分析以研究PL和HS在不同条件下的凋亡和增殖。进行长期细胞培养以测试PL随时间的增殖作用。长期培养表明,IH-1细胞可以在一定程度上利用PL作为培养基,但增殖太慢,无法将PL视为HS的良好替代品。 OH-2细胞不会在PL中长时间增殖,并且似乎无法摆脱对HS的依赖。与HS相比,KJON细胞在PL中的增殖速率较慢。凋亡测定通常显示在HS和PL中培养的细胞之间的存活率百分比上的细微差异,而增殖测定显示HS在刺激各个细胞系的细胞增殖方面更有效。如果要用替代的培养基补充剂代替HS​​,则这种类型的培养基应对细胞产生稳定且高度的增殖作用,并以与HS相同的程度支持生长和存活。 PL无法替代HS,因为它不能促进IH-1,KJON和OH-2细胞系的最佳生长和增殖。与HS相比,PL的处理既费时又不实用。

著录项

  • 作者

    Bruvoll Ingrid Engum;

  • 作者单位
  • 年度 2014
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号